FASCIA ILIACA BLOCK VERSUS INTRAVENOUS NALBUPHINE AS ANALGESIC METHOD BEFORE POSITIONING FOR SPINAL ANESTHESIA IN PATIENTS UNDERGOING SURGERY FOR HIP FRACTURES

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07613801

Enrollment

Registered

2026-05-29

Start date

2026-05-12

Completion date

2026-11-12

Last updated

2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fracture Surgeries

Brief summary

Investigators will compare FASCIA ILIACA BLOCK VERSUS INTRAVENOUS NALBUPHINE AS ANALGESIC METHOD BEFORE POSITIONING FOR SPINAL ANESTHESIA IN PATIENTS UNDERGOING SURGERY FOR HIP FRACTURES

Interventions

DRUGBupivacain

We will compare fascia ILIACA block with nalbuphine

DRUGNalbuphine

We will compare this with fascia ilaca block

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

30 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Age above 30 years

Exclusion criteria

* Age before 30

Design outcomes

Primary

Measure	Time frame	Description
Pain score(VAS score) after 15 minutes of either intervention before spinal anesthesia	15 minutes	—
Quality of positioning for spinal anesthesia after 15 minutes of either intervention	15 minutes	Scale of 0-3 for hip flexion while sitting after either intervention 0=not satisfactory (poor hip flexion) 1. satisfactory (slight hip flexion) 2. good (adequate hip flexion) 3. optimal (excellent hip flexion)

Secondary

Measure	Time frame	Description
Assessment of heart rate	15 minutes	Measured in beat per minute
Assessment of blood pressure	15 minutes	Measured in mmHg
Comfort of patient	15 minutes	Objective observational pain indicators reflecting the patient's acceptance and and tolerance of positioning. 0=calm 1. facial grimacing 2. moaning 3. screaming 4. unable to proceed due to agitation or restlessness

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026